China Pharmaceutical announced that the company signed the “Share Purchase Agreement for Shanghai Zezheng Pharmaceutical Technology Co., Ltd.” with 13 counterparties to purchase a total of 70% of the shares of Shanghai Zezheng Pharmaceutical Technology Co., Ltd. with a cash investment of 525 million yuan. Zesheng Pharmaceutical is a pharmaceutical research and development enterprise featuring improved new drugs and complex formulations. It provides full-process R&D services for drug research, clinical trials, and registration. The purpose of this transaction is to enhance the comprehensive strength of Chinese pharmaceuticals in the field of pharmaceutical R&D innovation, make up for shortcomings in the current R&D system, and open up the entire industry chain from R&D to production. The transaction has been reviewed and approved by the board of directors and does not need to be submitted to the shareholders' meeting for Once the transaction is completed, Zheng Pharmaceutical will become a holding subsidiary of China Pharmaceutical.

China Pharmaceutical announced that the company signed the “Share Purchase Agreement for Shanghai Zezheng Pharmaceutical Technology Co., Ltd.” with 13 counterparties to purchase a total of 70% of the shares of Shanghai Zezheng Pharmaceutical Technology Co., Ltd. with a cash investment of 525 million yuan. Zesheng Pharmaceutical is a pharmaceutical research and development enterprise featuring improved new drugs and complex formulations. It provides full-process R&D services for drug research, clinical trials, and registration. The purpose of this transaction is to enhance the comprehensive strength of Chinese pharmaceuticals in the field of pharmaceutical R&D innovation, make up for shortcomings in the current R&D system, and open up the entire industry chain from R&D to production. The transaction has been reviewed and approved by the board of directors and does not need to be submitted to the shareholders' meeting for Once the transaction is completed, Zheng Pharmaceutical will become a holding subsidiary of China Pharmaceutical.